Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115070) titled 'A prospective clinical study on the safety and efficacy of autologous plasma exosome therapy for dry eye syndrome' on Dec. 22, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Eye Hospital, Wenzhou Medical University

Condition: Dry Eye Syndrome

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Experimental group:15;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=301391

Published by HT Digital Content Services with permission from Health Daily Digest....